| Phase 4 |
| NCT02496988 |
Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas |
Cytokine-Induced Killer Cells |
Not Yet Recruiting |
| NCT06216340 |
Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes |
Obese |
Not Yet Recruiting |
| Phase 3 |
| NCT06867991 |
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune… |
Anti-N-Methyl-D-Aspartate Receptor Encephalitis |
Recruiting |
| Phase 2/3 |
| NCT02482454 |
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With… |
Cholangiocarcinoma |
Active, Not Recruiting |
| Phase 2 |
| NCT02487550 |
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating |
Renal Neoplasma |
Not Yet Recruiting |
| NCT02490735 |
CIK in Treating Patients With Esophageal Cancer |
Esophageal Squamous Cell Carcinoma |
Not Yet Recruiting |
| NCT02497898 |
Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma |
Lymphoma, Non-Hodgkin |
Not Yet Recruiting |
| NCT02498756 |
Cytokine-induced Killer Study for Patients With Stage II Melanoma |
Melanoma |
Not Yet Recruiting |
| NCT02493582 |
The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma… |
Adenocarcinoma of Lung |
Active, Not Recruiting |
| NCT02485015 |
The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced… |
Stomach Neoplasms |
Active, Not Recruiting |
| NCT02489890 |
CIK in Treating Patients With Bladder Cancer |
Urinary Bladder Neoplasms |
Active, Not Recruiting |
| NCT02487693 |
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With… |
Ovarian Carcinoma |
Active, Not Recruiting |
| NCT02490748 |
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With… |
Cervical Cancer |
Active, Not Recruiting |
| NCT02491697 |
Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced… |
Breast Cancer |
Active, Not Recruiting |
| NCT02487992 |
The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With… |
Colorectal Neoplasms |
Active, Not Recruiting |
| NCT05732662 |
SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC |
Recurrent or Metastatic Esophageal Squamous Cell Carcinoma |
Not Yet Recruiting |
| Phase 1/2 |
| NCT02494804 |
Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas |
Cytokine-Induced Killer Cells |
Not Yet Recruiting |
| Phase 1 |
| NCT02496273 |
Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer |
Gastric Cancer |
Active, Not Recruiting |
| Not specified |
| NCT06456515 |
Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC |
Colorectal Cancer Metastatic |
Recruiting |
| NCT06950242 |
Clinical Trial of Safety and Efficacy of Intracranial Laser Balloon Dilation Catheter in… |
Prospective, Multicenter, Randomized, Controlled, and Superior Efficiency |
Enrolling by Invitation |